Lyell Immunopharma, Inc.NASDAQ: LYEL

Lyell Immunopharma To Participate in November Investor Events

· Issued by Lyell Immunopharma, Inc. via GlobeNewswire

Summary by 6ix AI

Lyell Immunopharma, a late-stage clinical company developing CAR T-cell therapies (immune cells engineered to attack cancer), said members of its senior management team will participate in investor events hosted by Goldman Sachs, Stifel and Jefferies in November 2026.

Key details

  • Goldman Sachs' RxChange Series fireside chat, Framing Lyell's next-generation lymphoma CAR-T data in 4Q, on Thursday, November 5, 2026 at 11:00 am ET, featuring Alexander P. Boardman, MD, Associate Physician, Division of Hematology/Oncology, Mass General Brigham Cancer Institute; Faculty of Medicine, Harvard Medical School.
  • Stifel 2026 Healthcare Conference fireside chat and one-on-one meetings on Tuesday, November 10, 2026, at 4:00 pm ET; a live webcast and replay of the Stifel fireside chat will be available in the Investors section of www.lyell.com.
  • 2026 Jefferies Global Healthcare Conference one-on-one meetings on Wednesday, November 18, 2026.

6ix AI wrote this summary from the release below and checked it against the release.

SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior management team will participate in the following investor events:

Goldman Sachs’ RxChange Series: Framing Lyell’s next-generation lymphoma CAR-T data in 4Q
Format: Fireside Chat
Featured Speaker: Alexander P. Boardman, MD, Associate Physician, Division of Hematology/Oncology, Mass General Brigham Cancer Institute; Faculty of Medicine, Harvard Medical School
Date & Time: Thursday, November 5, 2026 at 11:00 am ET
Webcast Link: Here

Stifel 2026 Healthcare Conference
Format: Fireside Chat and 1x1 Meetings
Date & Time: Tuesday, November 10, 2026, at 4:00 pm ET
Webcast Link: Here

2026 Jefferies Global Healthcare Conference
Format: 1x1 Meetings
Date: Wednesday, November 18, 2026

A live webcast and subsequent replay of the Stifel fireside chat will be available in the Investors section of the Company's website at www.lyell.com.

About Lyell Immunopharma, Inc.

Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors. To realize the potential of cell therapy for cancer, Lyell utilizes a suite of technologies to arm CAR T cells with enhancements needed to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical responses, including the ability to resist exhaustion, maintain qualities of durable stemness and function in the hostile tumor microenvironment. Lyell’s proprietary LyFE Manufacturing Center™ has commercial launch capability and is expected to have the capacity to manufacture more than 1,200 CAR T-cell doses per year. To learn more, please visit www.lyell.com.

Contact:

Lyell Investor Relations
[email protected]

View original source (GlobeNewswire)Lyell Immunopharma, Inc. on 6ix

Story so far

Earlier from Lyell Immunopharma

Later from Lyell Immunopharma

All Lyell Immunopharma news releases